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investigation was stopped for fear of perforation. Histological
examination was consistent with ulcerative colitis of high
inflammatory activity. Routine screening for enterohaemorrhagic
E coli serotypes 026, 0111, and 0157 by slide agglutination was
negative. However, DNA colony blot hybridisation with synthetic
oligonucleotide probes2 constructed from the sequences reported
for shiga-like toxin type I and II genes3 gave positive signals with
both probes for 40 out of 55 E coli colonies selected at random from
an ’Endo’ agar plate inoculated with the stool specimen. As a
consequence the patient, who had been started 4 days earlier on
5-aminosalicylic acid and methylprednisolone, was also given
ciprofloxacin 500 mg twice a day for 10 days. The patient improved
rapidly and after another week his bowel habits had returned to
normal. Control stool specimens taken 1, 3, and 9 weeks after
antibiotic therapy were negative for VTEC by colony blot
hybridisation.
Using colony blot hybridisation, we have detected VTEC strains
in 3 more stool specimens from 17 patients with a diagnosis of
ulcerative colitis. In contrast none of 53 stools from healthy
individuals, all tested for at least 50 E coli colonies, were positive.
Interestingly serotyping yielded 02:H5 in all 4 cases. This 02
serotype has been listed as a verocytotoxin-producing strain.’
The fact that all 4 VTEC strains we found in association with
ulcerative colitis were 02:H5 and that most VTEC strains found in
association with haemorrhagic colitis and HUS are 0157:H7
suggests that the production of verocytotoxin I and/or II, though a
prominent feature of these strains, may not be their only pathogenic
property. Burke et al4 described special adhesive properties of E coli
from patients with ulcerative colitis and Crohn’s disease. Ljungh et
al5 observed collagen type II and fibronectin binding properties as
well as vero cell toxicity in E coli from similar patients. Neither
group, however, reported serotyping. Ljungh et al6 have also
presented a case report of a patient with ulcerative colitis from
whom they isolated VTEC 07:K7. After treatment with
mecillinam the patient improved. However, unlike our patient,
VTEC continued to be isolated from the stool during and after
antibiotic treatment. The role of antibiotics in the treatment of other
VTEC-associated diseases, such as haemorrhagic colitis or HUS, is
still unclear, and it has even been suggested’ that the use of
antibiotics is a risk factor for acquiring the infection. We
administered ciprofloxacin because this drug decreases
verocytotoxin synthesis in vitro" and, in clinical studies,9 eliminates
enteric pathogens from the gut mucosa.
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BREAST CANCER AND ORAL CONTRACEPTIVES
SIR,-Dr Le Fanu (June 3, p 1258) criticises the Committee on
Safety of Medicines (CSM) for failing to provide a "dispassionate
presentation of the facts" on breast cancer and oral contraceptives
(OC) usage. Specifically, he takes the Committee to task for
apparently ignoring Professor Peto’s reanalysis (March 11, p 552) of
the CASH study and for failing to give prominence to the increase in
breast cancer registrations, amongst women aged 25-34 years, by
two regional UK cancer registries.
Doctors and the public expect more from the CSM than a
dispassionate presentation of facts. Over a year ago the Committee
established a working party to review the scientific evidence, and to
monitor all new findings on the subject. The working party and the
CSM took account of all the available information in its recent
assessment of the risks and benefits of OC use. In formulating its
advice to the profession (Current Problems no 26) the CSM was
aware, through its international contacts, that Professor Stadel and
his colleagues (June 3, p 1257) were unable to confirm Peto’s
reanalysis of the CASH study. The Committee was also aware that
the increase in breast cancer registrations noted by the Southern
Thames and West Midlands registries began in the 1960s, too early
to be explained by OC usage. These changes have not, moreover,
been replicated in the UK as a whole.
When faced with the need to balance risks and benefits, the CSM,
like any individual prescriber, has to make a judgment based on all
the available evidence. Amongst the benefits of OC usage are not
only its contraceptive efficacy but also the protection it offers against
ovarian and endometrial cancer. We make no apology for taking a
broad view of the effects of modem medicines and will continue to
monitor all work on breast cancer and OC usage.





PROPORTION OF NEWLY OBESE AND CHRONIC
OBESE AT DIFFERENT AGES
SiR,&mdash;Most studies of obesity are purely cross-sectional in
nature, comparing parents and children, or obese probands with
other family members. However, the obese do not necessarily
remain obese, and obesity may be attained at any age from
childhood through middle age.!,2 Accordingly, we do not know
what proportion of obese people has been obese for long (ie, chronic
obesity) and what proportion represents the newly obese (recent
obesity). Nor do we know whether the newly obese and the chronic
obese have similar familial origins.
To answer these questions we have made a retrospective study of
1140 obese people derived from a total population sample with over
95% compliance.3 All were obese at the time of a later examination,
obesity here being defmed with respect to the 84th percentile (+ 1Z)
for the sum of two skinfolds for age and sex.’ Those who had been
similarly obese at an earlier examination were defined as long-term
or chronic obese while those not obese at the previous examination
were defmed as newly obese. The study was therefore retrospective,
using fully longtitudinal data and the same diagnostic criterion at all
age groups from childhood (5-9 years) through the 4th decade
(30-39). Problems of skewness and kurtosis for the summed
skinfolds (triceps and subscapular) were obviated by the use of
centiles and normalised Z-scores throughout. 5
At least half of the 220 obese children, 468 obese adoles xnts, and
452 obese adults were not obese at a previous examination.
Moreover, the percentage deemed newly obese was highest (76%)
in the youngest age group and fell steadily to 50% in early and
middle adulthood. The trends were similar in males and females
(table). Age by age, then, and for both sexes, the newly obese
comprised a large but declining proportion of the obese while the
long-term or chronic obese increased in relative numbers but did
not exceed 50% even in the 30-39 age group.
We are aware that the proportion of newly obese individuals is a
function of the interval between examinations, just as the prevalence
of obese individuals is necessarily a function of the obesity criterion
used. However, our findings were based on the same obesity criteria
and the same examination intervals. These findings are also
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Source: Tecumseh, Michigan, community health survey, examination rounds.
consistent with prospective data indicating that the obese do not
necessarily remain obese and that the cadre of obese individuals is
continually replenished by recruitment from the ranks of the
non-obese. Even in the middle years, at least half of the obese
comprise the newly obese, thus providing an indication of the
incidence of obesity (new cases per 5 year interval) rather than its
prevalence.
These data, that effectively divide the obese into the newly obese
and the chronic obese, hold major implications for the study of
obesity, especially in family studies. We would not expect the newly
obese and the chronic obese to be identical in socioeconomic origins
or to derive from families of comparable parental and sibling
fatness. Indeed, parent-child and sibling similarities in measured
fatness may well be different for the newly obese and for those with
long-established obesity. The living-together or cohabitational
factor in familial obesity6.7 may also be different for the newly and
the chronic obese. Years of living in an obese family may have a
greater bearing on chronic obesity than on obesity of recent onset.
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IN-VITRO STUDY OF IMMUNE RESPONSES IN LOIN
PAIN/HAEMATURIA SYNDROME
SIR,-In loin pain/haematuria syndrome recurrent unilateral or
bilateral loin pain is accompanied by frank or microscopic
haematuria.! Renal biopsy often reveals abundant granular deposits
of C3 in arteriolar walls,2 and angiography may demonstrate
abnormalities in intrarenal vessels. 3 Exaggerated type 3
hypersensitivity reactions after intradermal injections of recall
antigens have been described in patients with this condition and
suggest that it may represent a hypersensitivity state.4 We have
examined cellular and humoral immune responsiveness in vitro of
eight patients with the syndrome, using antigens shown to cause
abnormal skin reactions.
The diagnosis was based on clinical and renal biopsy findings.
We looked at T-cell proliferation and serum antibody levels in
response to antigen and at T-cell phenotype in the patients and in 4
healthy volunteers. Peripheral blood mononuclear cells were
cultured for 5 days with the non-specific T-cell stimulator
concanavalin A (3-50 g/ml), human and bovine tuberculin
purified protein derivative (PPD) (3-100 g/ml), and streptococcal
varidase (1/50 to 1/300 dilutions of streptokinase 100 U/ml plus
streptodornase 25 U/ml). The cells were then pulsed with tritiated
thymidine. T-cell phenotype was determined by incubating
mononuclear cells with mouse monoclonal antibodies to human
lymphocyte surface markers T3, T4, and Tg. The cells were washed
and resuspended with fluorescence-labelled goat anti-mouse-
immunoglobulin and analysed in a fluorescence-activated cell
sorter. Serum antibody levels to PPD or varidase were measured by
ELISA. Serum was incubated on microtitre plates coated with
antigen (10 fig/mi) and bound antibodies were reacted with goat
and-human-immunoglobulin alkaline phosphatase conjugate.
After incubation with phosphate substrate absorbance at 405 nm
was read on a Flow ’Multiscan’ plate reader.
T-cell proliferation, expressed as a stimulation index, was no
different in patients and controls. Although T 8 counts were low in
three patients, patients and controls did not differ as a group; nor did
the T4/Tg ratio. Antibodies to human and bovine PPD were present
in sera from all patients and controls and there was no difference
between the mean absorbance values. Cutaneous hypersensitivity in
four of the patients has aleady been reported’ and has since been
studied in a fifth patient. There was no clear relation between the
skin and the in-vitro responses or between in-vitro responses and
symptom severity. Indeed in two patients whose symptoms were
severe enough to merit renal autotransplantation, one produced no
T-cell response to any of the antigens whilst the other responded to
all of them.
The cutaneous hypersensitivity seen in patients with the loin
pain/haematuria syndrome was unequivocal4 and similar
observations have subsequently been made by others (Clarkson
AR, personal communication). It is therefore surprising that a study
of the mechanisms involved in such responses provides no evidence
of hypersensitivity. However, 3-4 years had elapsed between the
skin tests and the in-vitro analyses reported here. Also the patients
were all well at the time of this study, and perhaps the tests should be
repeated during episodes of pain. Since a relative increase in
T-helper response would heighten immune responsiveness, the low
T 8 values in three of the patients is of interest. However, this must
be interpreted with caution because the group mean was not
significantly reduced and T-cells cannot be confidently assigned to
helper or suppressor subgroups solely on the basis of their T and Tg 8
phenotype. Furthermore one patient who had a low T count
produced a strong cutaneous reaction to varidase but none to PPD,
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NURSERY-ACQUIRED ASYMPTOMATIC
B HEPATITIS
SIR,-L. Gray Davis and colleagues (April 22, p 889) suggest that
horizontal transmission of hepatitis B virus (HBV) may occur in
pre-school day-care centres. The following case-report could
support this view.
A previously health 12-year-old boy was brought to the
paediatric ward showing signs of contact with eye-shadow on his
lips and tongue. On examination the only striking finding was mild
hepatosplenomegaly. However, laboratory tests revealed raised
levels of aspartate (AST 912 IU/1) and alanine (AST 1284 IU/1)
aminotransferase. These results were confirmed 2 days later.
Alkaline phosphatase (1028 IU/1), y-glutamyltransferase (76 IU/1),
and lactate dehydrogenase (445 IU/1) activities were also increased.
Total bilirubin was 0.03 mg/dl.
Tests for HBV serum markers pointed to active HBV infection
(HBsAg, HBeAg, and HBV-DNA all positive). Viral culture
